Page last updated: 2024-10-25

deferoxamine and Aprosodia

deferoxamine has been researched along with Aprosodia in 2 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Research Excerpts

ExcerptRelevanceReference
"In the first case, paranoid delusions, visual hallucinations, seizures and deteriorating speech followed each dialysis treatment with DFO."1.28Exacerbation of aluminium encephalopathy after treatment with desferrioxamine. ( McCauley, J; Sorkin, MI, 1989)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ogura, Y1
Yokoyama, K1
Ohara, M1
McCauley, J1
Sorkin, MI1

Other Studies

2 other studies available for deferoxamine and Aprosodia

ArticleYear
[Dialysis encephalopathy].
    Nihon rinsho. Japanese journal of clinical medicine, 1992, Volume: 50 Suppl

    Topics: Anticonvulsants; Apraxias; Deferoxamine; Dementia; Electroencephalography; Humans; Kidney Failure, C

1992
Exacerbation of aluminium encephalopathy after treatment with desferrioxamine.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1989, Volume: 4, Issue:2

    Topics: Aged; Aluminum Hydroxide; Deferoxamine; Hallucinations; Humans; Male; Memory Disorders; Middle Aged;

1989